Related Experiment Video
Updated: Jul 15, 2025

Author Spotlight: Advancing Antibiotic Resistance Research Using an Efflux-Deficient Bacterial Strain and a Single-Copy Gene Expression System
Published on: January 5, 2024
Advances in the Discovery of Efflux Pump Inhibitors as Novel Potentiators to Control Antimicrobial-Resistant
Song Zhang1, Jun Wang2, Juhee Ahn1,3
1Department of Biomedical Science, Kangwon National University, Chuncheon 24341, Republic of Korea.
Abstract:
The excessive use of antibiotics has led to the emergence of multidrug-resistant (MDR) pathogens in clinical settings and food-producing animals, posing significant challenges to clinical management and food control. Over the past few decades, the discovery of antimicrobials has slowed down, leading to a lack of treatment options for clinical infectious diseases and foodborne illnesses. Given the increasing prevalence of antibiotic resistance and the limited availability of effective antibiotics, the discovery of novel antibiotic potentiators may prove useful for the treatment of bacterial infections. The application of antibiotics combined with antibiotic potentiators has demonstrated successful outcomes in bench-scale experiments and clinical settings. For instance, the use of efflux pump inhibitors (EPIs) in combination with antibiotics showed effective inhibition of MDR pathogens. Thus, this review aims to enable the possibility of using novel EPIs as potential adjuvants to effectively control MDR pathogens. Specifically, it provides a comprehensive summary of the advances in novel EPI discovery and the underlying mechanisms that restore antimicrobial activity. In addition, we also characterize plant-derived EPIs as novel potentiators. This review provides insights into current challenges and potential strategies for future advancements in fighting antibiotic resistance.
Insights
Novel antibiotic potentiators, like efflux pump inhibitors (EPIs), can combat multidrug-resistant pathogens. Combining EPIs with antibiotics offers a promising strategy to overcome antibiotic resistance challenges in clinical and food settings.
Area of Science:
- Microbiology
- Pharmacology
- Drug Discovery
Background:
- Excessive antibiotic use drives multidrug-resistant (MDR) pathogen emergence in clinical and agricultural settings.
- A decline in new antimicrobial discovery limits treatment options for bacterial infections.
- Antibiotic resistance poses a significant global health and food safety challenge.
Purpose of the Study:
- To review advances in novel antibiotic potentiator discovery, focusing on efflux pump inhibitors (EPIs).
- To explore the mechanisms by which EPIs restore antimicrobial activity.
- To highlight plant-derived EPIs as potential adjuvants for combating MDR pathogens.
Main Methods:
- Comprehensive literature review of novel EPI discovery and mechanisms.
- Analysis of studies demonstrating the efficacy of antibiotic-EPI combinations.
- Characterization of plant-derived compounds as potential EPIs.
Main Results:
- Efflux pump inhibitors (EPIs) combined with antibiotics effectively inhibit MDR pathogens.
- Novel EPIs restore the activity of existing antibiotics against resistant strains.
- Plant-derived compounds show potential as novel EPIs.
Conclusions:
- Novel EPIs represent a promising strategy to potentiate existing antibiotics and overcome MDR pathogens.
- Combining antibiotics with EPIs offers a viable approach to manage bacterial infections and foodborne illnesses.
- Further research into EPIs, particularly plant-derived ones, is crucial for developing new treatments against antibiotic resistance.
Related Concept Videos
Development of Antibiotic Resistance
Combined Effects of Drugs: Synergism
Such synergistic combinations...
Carrier-Mediated Transport
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
Gene Regulation in Microbial Communities: Quorum Sensing
Antimicrobial Proteins
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Antimicrobial Effectiveness

